We have examined possible regulation of norepinephrine and dopamine concentrations and turnover in the right ventricle of the rat after acute administration of saline i.p. or morphine 30 mg kg -1 i.p. to placebo (naïve) or morphine (tolerant) pretreated rats. We also assessed concentrations of 3Ј,5Ј-cyclic adenosine monophosphate (cAMP) in the right ventricle after the same treatments. Concentrations of catecholamines and their metabolites in the heart were measured by high-pressure liquid chromatography with electrochemical detection (HPLC/ DE). Concentrations of cAMP in the heart were measured by radioimmunoassay (RIA). Administration of morphine to naïve rats did not modify concentrations of norepinephrine (NE), normetanephrine (NMN) or NMN/NE ratio in the right ventricle. However, dopamine concentrations increased whereas dopamine turnover decreased. In addition, cAMP concentrations decreased after acute administration morphine to naïve rats. In rats pretreated with morphine chronically, there was an increase in norepinephrine concentrations with no change in normetanephrine concentrations or norepinephrine turnover after acute injection of morphine. In contrast, dopamine turnover increased in the tolerant groups after acute injection of saline or morphine compared with the naïve group given morphine, indicating that tolerance develops to the acute effects of the opioid. Concentrations of cAMP increased after chronic morphine administration. Our results demonstrate that chronic morphine pretreatment leads to up-regulation of the cAMP system in the heart and suggest that this up-regulation may be involved in the cellular mechanisms implicated in the adaptive changes of dopaminergic neurones in the heart observed during chronic treatment with morphine. 1999; 83: 784-8 
Opioid peptides have been shown to have a wide tissue the response to opioids and in the development of tolerance and dependence. 7 Many compensatory mechanisms have distribution and are known to control cardiac function via reflex mechanisms involving the central nervous system been described in the central nervous system, including upregulation of the 3Ј,5Ј-cyclic adenosine monophosphate or modulation of neurotransmitter release from neurones located within the heart. 1 The discovery that mammalian (cAMP) system and alteration of gene expression. 8 9 Catecholaminergic systems play an important role in the myocardial cells have opioid receptors [2] [3] [4] [5] [6] led to studies aimed at investigating direct myocardial effects caused development and maintenance of opioid tolerancedependence and in the effects on drug withdrawal, as has by opioid receptor stimulation and identifying possible intracellular opioid pathways.
been shown in several neuronal models such as the locus coeruleus and nucleus accumbens. 7 10 Repeated use of opioids induces adaptive changes in the central and peripheral nervous system, leading to developDespite substantial evidence that catecholaminergic neurones in the locus coeruleus and projections to the ment of tolerance and dependence. Several animal models have been used to investigate the mechanisms involved in hypothalamus are involved in opioid tolerance-depend-ence, 10 11 there are few data on alterations of heart catechol-Estimation of catecholamines and their metabolites aminergic neurones during morphine tolerance and in the right ventricle dependence. It has been suggested that chronic administra-After decapitation, the chest was opened using a mid-sternal tion of U-50,488H induced tolerance to cardiac function, incision and the right ventricle was dissected and stored which was not accompanied by down-regulation of κ immediately at -80°C. Norepinephrine and its metabolite binding sites. 12 In addition, previous studies in our labora-normetanephrine, and dopamine and its metabolite 3,4-tory demonstrated that acute administration of morphine in dihydroxyphenyl acetic acid (DOPAC) were measured by morphine-treated rats produced a decrease in the turnover high-pressure liquid chromatography with electrochemical of dopamine in auricular tissues which could be responsible detection (HPLC/ED). Each tissue was weighed, placed in a for the decrease in force and frequency of contraction dry-cooled propylene vial and homogenized with a Polytronobserved in in vitro experiments. 13 14 type homogenizer (setting 4 for 40 s) in perchloric acid As tolerance may include the central and peripheral 1.5 ml (0.1 mol litre -1 ). The homogenates were centrifuged nervous system, the aim of our study was to elucidate the (20 000 rpm, 4°C, 15 min), the supernatant layer removed role of norepinephrine and dopamine systems in the cardiac into a 1-ml syringe and filtered through a 0.45-µm filter response to acute morphine injection and the adaptive (Millipore) and centrifuged (15 000 rpm, 4°C, 20 min) changes on chronic morphine administration. Thus we again through Ultrafree MC 0.2 (Millipore). Each sample measured norepinephrine and dopamine content and turn-(10 µl) was injected into a 5-µm C 18 reverse-phase column over in the right ventricle of the rat after chronic morphine (Waters) through a Rheodyne syringe-loading injector administration. We also examined modulation of cAMP 200-µl loop. Electrochemical detection was accomplished formation in the right ventricle in response to morphine with a glassy carbon electrode set at a potential of ϩ0.65 V treatment.
vs the Ag-AgCl reference electrode (Waters). The mobile phase consisted of a 95:5 (v/v) mixture of water and methanol with sodium acetate 50 mmol litre -1 , citric acid
Materials and methods
20 mmol litre -1 , 1-octyl-sodium sulphonate 3.75 mmol The study was approved by the Local Animal Use Commit-litre -1 , di-n-butylamine 1 mmol litre -1 and EDTA tee. Male Sprague-Dawley rats (200-300 g at the beginning 0.135 mmol litre -1 , adjusted to pH 4.3. Flow rate was of treatment) were housed 4-5 per cage under a 12-h 0.9 ml min -1 and chromatographic data were analysed using light-dark cycle in a room with controlled temperature Millennium 2010 Chromatography Manager (Millipore) (22Ϯ11°C), humidity (50Ϯ10%) and food and water ad equipment.
libitum.
DOPAC, norepinephrine, normetanephrine and dopamine were simultaneously detected by the HPLC method at elution times of 3.12, 4.00, 7.00 and 10.70 min, respectively.
Experimental procedure
Norepinephrine, dopamine and their respective metabolites On the basis of previous studies, 13-17 rats were rendered were quantified by reference to calibration curves run at tolerant to morphine by subcutaneous implantation of morthe beginning and end of each series of assays. Linear phine base pellets (75 mg), one on day 0, two on day 2 relationships were observed between the amount of standard and three on day 4, under light ether anaesthesia. This injected and measured peak heights. The content of treatment results in a profound state of tolerance-dependnorepinephrine, dopamine, normetanephrine and DOPAC ence. 18 Naïve animals were implanted with placebo pellets in the right ventricle was expressed as ng g -1 wet weight containing lactose at the same time. On day 7, animals of tissue. were treated acutely with saline i.p. or morphine 30 mg kg -1 i.p. and killed 30 min later. There were four experimental
Measurement of cAMP in the right ventricle
groups for measurement of catecholamines in the right ventricle: (1) chronic placebo (naïve)-acute saline i.p.; Concentrations of cAMP were measured by radioimmuno-(2) chronic placebo (naïve)-acute morphine i.p.; (3) chronic assay ( 125 I-TME-S-cAMP, Diagnostic Pasteur, France) morphine (tolerant)-acute saline i.p.; and (4) chronic mor-according to the manufacturer's instructions. After dissecphine (tolerant)-acute morphine i.p. Another four groups, tion, the right ventricle was weighed and homogenized in who received the same treatments, were used for cAMP cold perchloric acid 1.5 ml (0.3 mol litre -1 ) with a Polytron analysis in the right ventricle. Weight gain of the rats was homogenizer and centrifuged (12 000 rpm, 4°C, 15 min). checked to ensure that morphine was liberated correctly The supernatants were treated with potassium phosphate from the pellets as it is known that chronic morphine until pH 6.2 was reached. The sensitivity of the assay was treatment induces a decrease in body weight gain because 2 pmol ml -1 . Intra-and inter-assay coefficients of variation of lower caloric intake. 19 In addition, on the day of the were 7.7% and 8.2%, respectively. The antibody crossexperiment, body weight was measured immediately before reacted 100% with 3Ј,5Ј-cAMP and less than 0.3% with injection of saline or morphine and 30 min later, immediately other nucleotides. cAMP concentrations were expressed as nmol g -1 of tissue. before killing.
Drugs and chemicals
Pellets of morphine base (Alcaliber Labs., Madrid, Spain) or lactose were prepared by the Department of Pharmacy and Pharmaceutic Technology (School of Pharmacy, Granada, Spain). Norepinephrine bitartrate, normetanephrine, dopamine HCl and DOPAC (used as HPLC standards) were purchased from Sigma Chemical Co. (St Louis, MO, USA). Morphine HCl (Alcaliber Labs., Madrid, Spain) was prepared fresh daily, dissolved in sterile 0.9% NaCl (saline) and injected in volumes of 0.15 ml/100 g body weight.
Other reagents were of analytical grade.
Statistical analysis
Data are expressed as mean (SEM). The significance of differences in content of norepinephrine (NE), normetanephrine (NMN), dopamine (DA) and DOPAC, and in NMN/NE and DOPAC/DA ratios were determined by analysis of variance followed by the Newman-Keuls test, using a computer program. 20 The non-paired Student's t test was used when comparing mean changes in body weight. Significance was taken as PϽ0.05.
Results
Rats rendered tolerant to morphine showed a significantly lower gain in body weigh on day 7 than groups treated Norepinephrine concentrations and turnover after acute or chronic morphine administration compared with the corresponding naïve group. Dopamine Acute administration of morphine 30 mg kg -1 i.p. to turnover increased in the tolerant group injected with saline naïve rats did not alter normetanephrine concentrations or compared with the naïve group injected with morphine, norepinephrine turnover (as estimated using the NMN/NE indicating that tolerance develops to the decreased dopamine ratio) (Fig. 1 ). Figure 1 also shows norepinephrine content turnover by morphine (Fig. 2) . In the morphine-pretreated and turnover in rats rendered tolerant to morphine. The rats, acute injection of morphine increased DOPAC concenmorphine-pretreated group injected acutely with saline on trations and dopamine turnover compared with the naïve day 7 showed no changes in norepinephrine or normetagroup injected with morphine. In addition, there were nephrine concentrations or norepinephrine turnover comsignificant differences in the concentrations of dopamine pared with the corresponding naïve group. In rats rendered and DOPAC between the two morphine-pretreated groups tolerant to the opioid, concentrations of norepinephrine injected with saline i.p. or morphine i.p. increased significantly 30 min after injection of morphine, with no changes in normetanephrine content or cAMP concentrations after acute or chronic norepinephrine turnover.
morphine administration Dopamine concentrations and turnover after acute
Concentrations of cAMP in the right ventricle obtained and chronic morphine administration from rats implanted with placebo or morphine pellets are shown in Figure 3 . Morphine 30 mg kg -1 given to placebo Acute administration of morphine 30 mg kg -1 i.p. to naïve pretreated rats produced a decrease in cAMP concentrations rats increased significantly concentrations of dopamine, compared with the naïve group injected with saline. In whereas dopamine turnover (as estimated using the DOPAC/ morphine-tolerant rats, cAMP concentrations 30 min after DA ratio) decreased. The morphine-pretreated group saline i.p. or morphine i.p. were significantly higher than injected acutely with saline showed no changes in dopamine concentrations whereas DOPAC concentrations increased those obtained in their respective control groups. existence of a dopaminergic system in the heart. We found that norepinephrine turnover in the ventricle after chronic morphine administration was similar to that found after acute injection of the opioid. However, chronic morphine exposure evoked a decrease in dopamine turnover, indicating that tolerance develops to the effects of morphine on the dopamine system in the right ventricle. In contrast, previous studies in our laboratory demonstrated that administration of morphine to morphine-pretreated rats caused a decrease in dopamine turnover in auricular tissues. 13 14 These differences suggest that chronic morphine treatment induces different adaptive changes in the heart depending on the tissue examined (atria or ventricle).
It has been demonstrated previously that development of tolerance to the mechanical effects of U-50,488H in the heart after chronic treatment with the agonist was not and DOPAC/DA ratio in placebo (naïve) and morphine-pretreated (tolerant) accompanied by down-regulation of κ binding sites, 12 rats, 30 min after acute injection of saline i.p. or morphine 30 mg kg -1 i.p. suggesting that tolerance in the heart may be associated Values are mean (SEM); nϭ5-6 per group. ‡ ‡ ‡PϽ0.001 vs placeboϩsaline; with a functional change in heart neurones, unrelated to the ***PϽ0.001 vs placeboϩmorphine; † †PϽ0.01, † † †PϽ0.001 vs receptor system. Collectively, these findings and our results morphineϩsaline. support the hypothesis that dopaminergic neurones may be implicated in the adaptive changes observed in the heart Discussion after chronic exposure to the drug.
We found that acute treatment with morphine to placeboThe mechanisms underlying the actions of chronic opioid administration and the manner in which responses to mor-pretreated rats produced a decrease in cAMP concentrations in the right ventricle. It is believed widely that acute activation phine are co-ordinated in cardiac tissue are not well understood. We have investigated the adaptive changes in heart of opioid receptors involves inhibition of neuronal activity.
This inhibition is caused by co-ordinated changes at the celnorepinephrine and dopamine neurones and concomitant opioid modulation of cAMP formation on exposure to the lular level including, possibly, inhibition of cAMP formation. 25 Thus previous studies in neuronal cells have indicated preferential µ agonist morphine.
Our results showed that acute injection of morphine that all three subtypes of opioid receptor inhibit adenylate cyclase in a pertussis toxin-sensitive manner. [26] [27] [28] [29] Also, in to placebo-pretreated rats did not produce changes in norepinephrine turnover, whereas DOPAC/DA ratio (an neurones of cardiac tissues, stimulation of opioid receptors reduces cAMP concentrations. 30 31 Our results are in agreeindex of dopamine turnover) decreased. These data indicate that the effects of morphine in the ventricle were associated ment with studies showing that cAMP concentrations in the ventricle decrease after acute morphine administration. with a decrease in the activity of dopaminergic neurones. The possible distribution of dopaminergic inputs through Whereas acute opioid administration inhibits adenylate cyclase activity, chronic opioid treatment leads to upthe heart is not known, although previous studies found detectable concentrations of dopamine in the heart. 21 22 In regulation of the cAMP system in different brain regions. 8 32 33 addition, it has been demonstrated that D 1A and D 4 receptor genes were expressed in the atria and ventricle of rat Despite substantial evidence that the cAMP system in the central nervous system is involved in opioid tolerance, heart. 23 24 Hence, these findings and our results suggest the and heart rate in chronically morphine-treated rats. Br J Anaesth there are no data on the characteristics of the functional ing the changes induced in the heart in subjects dependent 
